Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation
Clinical trial NCT00874419 · COMPLETED
Trial details
- NCT number
- NCT00874419
- Sponsor
- Tongji University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2010-07-01
- Enrollment
- 165
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.